Correlation Between Pfizer and ProShares Ultra

Can any of the company-specific risk be diversified away by investing in both Pfizer and ProShares Ultra at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and ProShares Ultra into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pfizer Inc and ProShares Ultra VIX, you can compare the effects of market volatilities on Pfizer and ProShares Ultra and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of ProShares Ultra. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and ProShares Ultra.

Diversification Opportunities for Pfizer and ProShares Ultra

0.76

Correlation Coefficient

Pfizer  ProShares Ultra

Poor diversification

The 3 months correlation between Pfizer and ProShares is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and ProShares Ultra VIX in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ProShares Ultra VIX and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with ProShares Ultra. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ProShares Ultra VIX has no effect on the direction of Pfizer i.e., Pfizer and ProShares Ultra go up and down completely randomly.

Pair Corralation between Pfizer and ProShares Ultra

Considering the 90-day investment horizon Pfizer Inc is expected to generate 0.27 times more return on investment than ProShares Ultra. However, Pfizer Inc is 3.65 times less risky than ProShares Ultra. It trades about -0.16 of its potential returns per unit of risk. ProShares Ultra VIX is currently generating about -0.06 per unit of risk. If you would invest  2,961  in Pfizer Inc on September 15, 2024 and sell it today you would lose (403.00) from holding Pfizer Inc or give up 13.61% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Pfizer Inc  vs.  ProShares Ultra VIX

Pfizer Inc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

ProShares Ultra VIX

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days ProShares Ultra VIX has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Etf's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the ETF investors.

Pair Trading with Pfizer and ProShares Ultra

The main advantage of trading using opposite Pfizer and ProShares Ultra positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, ProShares Ultra can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ProShares Ultra will offset losses from the drop in ProShares Ultra's long position.

The idea behind Pfizer Inc and ProShares Ultra VIX pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.